Biogen's HQ plans change, thanks to early Tecfidera success

What happens when a new drug comes charging out of the launch gate? For Biogen Idec ($BIIB), it means a rethink of its real estate plans. Its fast-growing staff won't all fit in the new headquarters under construction in Cambridge, MA. Report

document.addEventListener("googletagEvent", function() { googletag.cmd.push(function() { googletag.display('ad-slot_1__mobile'); }); });
Read more on